Startups
Priothera

Priothera

https://priothera.com

Priothera is developing the orally applied sphingosine 1 phosphate (S1P) receptor modulators for haematological malignancies.

Summary

Seedtable Score
  • 15
Locations
Company Size
  • 11 to 50 employees
Last Stage Round
Industry

Total funding Amount

$57M

Fundraising History

Investors